Indeed, although ANG2 levels are comparable in plasma of patients at diagnosis of their metastatic disease and after resistance to chemotherapy, STC1 levels are clearly higher following progression on several lines of chemotherapy. Here, ANGPT2 is linked to metastatic neoplasm.